SNI (Shenni Holdings) Sloan Ratio %: 20.92% (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Shenni Holdings Sloan Ratio %?

Shenni Holdings SNI Sloan Ratio % is 20.92% as of Sep. 2024.

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Shenni Holdings's Sloan Ratio for the quarter that ended in Sep. 2024 was 20.92%.

As of Sep. 2024, Shenni Holdings has a Sloan Ratio of 20.92%, indicating there is a warning stage of accrual build up.


Shenni Holdings  (NAS:SNI) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2024, Shenni Holdings has a Sloan Ratio of 20.92%, indicating there is a warning stage of accrual build up.


Shenni Holdings Sloan Ratio % Related Terms


Shenni Holdings Sloan Ratio % Historical Data

* Premium members only.

The historical data trend for Shenni Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenni Holdings Sloan Ratio % Chart

Shenni Holdings Annual Data
Trend Mar23 Mar24
Sloan Ratio %
58.88 -12.79

Shenni Holdings Semi-Annual Data
Mar23 Sep23 Mar24 Sep24
Sloan Ratio % 0.00 0.00 -12.79 20.92

SNI vs : Sloan Ratio % Comparison

For the Medical Devices subindustry, Shenni Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenni Holdings Sloan Ratio % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenni Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Shenni Holdings's Sloan Ratio % falls into.



Shenni Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Shenni Holdings's Sloan Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (A: Mar. 2024 )-Cash Flow from Operations (A: Mar. 2024 )
-Cash Flow from Investing (A: Mar. 2024 ))/Total Assets (A: Mar. 2024 )
=(1.538-3.107
--0.32)/9.764
=-12.79%

Shenni Holdings's Sloan Ratio for the quarter that ended in Sep. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2024 )
=(3.225-1.469
--0.565)/11.097
=20.92%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Shenni Holdings's Net Income for the trailing twelve months (TTM) ended in Sep. 2024 was 1.36 (Mar. 2024 ) + 1.865 (Sep. 2024 ) = $3.23 Mil.
Shenni Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2024 was 0.333 (Mar. 2024 ) + 1.136 (Sep. 2024 ) = $1.47 Mil.
Shenni Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2024 was -0.245 (Mar. 2024 ) + -0.32 (Sep. 2024 ) = $-0.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Sloan Ratio % →
What does a Sloan Ratio % of 20.92% mean?
Shenni Holdings (SNI) has a Sloan Ratio % of 20.92% as of Sep. 2024. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Shenni Holdings and its competitors.
Is Shenni Holdings' Sloan Ratio % too high?
Shenni Holdings' current Sloan Ratio % is 20.92%.
How does Shenni Holdings' Sloan Ratio % compare to ?
Shenni Holdings' Sloan Ratio % of 20.92% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Medical Devices & Instruments company?
A good Sloan Ratio % depends on the Medical Devices & Instruments industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Shenni Holdings and its competitors. Shenni Holdings's current Sloan Ratio % is 20.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenni Holdings stock overvalued right now?
Shenni Holdings (SNI) has a current Sloan Ratio % of 20.92%. The current Sloan Ratio % is 20.92%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Shenni Holdings (SNI), the current Sloan Ratio % is 20.92% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shenni Holdings Business Description

Comparable Companies
Address Biopharmaceutical Industry Park, South Bridge Yongfeng County, Jiangxi Province, Jian, CHN, 331500
Shenni Holdings Ltd is a holding company. Through its operating subsidiaries in China, it is engaged in the business of the manufacture and distribution of urology medical devices and care products as well as the distribution of cardiovascular and cerebrovascular medical devices. Its products include Guide Wire, Catheter Sheath, and PTA Balloon Catheter. The company derives its revenue from three sources: (i) sales and distribution of urology medical devices (ii) sales and distribution of urology care products, and (iii) sales and distribution of cardiovascular and cerebrovascular medical devices.